Open AccessIntravesical therapy for urothelial carcinoma of the bladder
Author(s) -
Murugesan Manoharan
Publication year - 2011
Publication title -
indian journal of urology/indian journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.333
H-Index - 30
eISSN - 1998-3824
pISSN - 0970-1591
DOI - 10.4103/0970-1591.82846
Subject(s) - medicine , bladder cancer , urology , context (archaeology) , urothelial carcinoma , resection , oncology , cancer , surgery , paleontology , biology
Transurethral resection is an effective therapy for non-muscle-invasive bladder cancer. However, the high rates of recurrence and significant risk of progression in higher grade tumors mandates additional therapy with intravesical agents. In this review we discuss the role of various intravesical agents currently in use including the immunomodualtory agent BCG and chemotherapeutic agents. We discuss the current guidelines and the role of these therapeutic agents in the context of higher grade Ta and T1 tumors.